Single-dose flu pill wins FDA approval ahead of winter season

Wednesday, October 24, 2018 - 13:21 in Mathematics & Economics

U.S. approval of the first novel anti-flu pill in two decades has doctors cautiously optimistic about a simpler treatment for a virus that killed almost 200 American children last season. The drug, which is to be marketed globally by Shionogi & Co. and Roche Holding AG, gained Food and Drug Administration...

Read the whole article on LA Times - Science

More from LA Times - Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net